|
| | Cefpimizole sodium Basic information |
| Product Name: | Cefpimizole sodium | | Synonyms: | AC 1370;Ajicef;Pyridinium, 1-[[(6R,7R)-2-carboxy-7-[[(2R)-[[(5-carboxy-1H-imidazol-4-yl)carbonyl]amino]phenylacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-4-(2-sulfoethyl)-, inner salt, monosodium salt;Pyridinium, 1-[[2-carboxy-7-[[[[(5-carboxy-1H-imidazol-4-yl)carbonyl]amino]phenylacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-4-(2-sulfoethyl)-, inner salt, monosodium salt, [6R-[6α,7β(R*)]]-;Renilan;U 63196E;cefpimizole sodium;Sodium (6R,7R)-7-[[(2R)-2-[(2-carboxy-3H-imidazole-4-carbonyl)amino]-2-phenylacetyl]amino]-8-oxo-3-[[4-(2-sulfonatoethyl)pyridin-1-ium-1-yl]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | | CAS: | 85287-61-2 | | MF: | C28H25N6NaO10S2 | | MW: | 692.65 | | EINECS: | | | Product Categories: | | | Mol File: | 85287-61-2.mol |  |
| | Cefpimizole sodium Chemical Properties |
| alpha | D20 -28.2° (c = 0.5 in water) |
| Toxicity | LD50 in male, female mice, male, female rats (g/kg): 2.7, 2.9, 4.2, 3.5 i.v.; 8.2, 6.8, 12.2, 11.5 s.c.; all >15.0 orally (Hashimoto) |
| | Cefpimizole sodium Usage And Synthesis |
| | Cefpimizole sodium Preparation Products And Raw materials |
|
